<!DOCTYPE html>

<html lang="en">
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title></title>
	<link rel="stylesheet" href="css/ka.css" type="text/css" />
	<link rel="stylesheet" href="css/animate.css" type="text/css" />
	<script type="text/javascript" src="js/base.js"></script>
	<script type="text/javascript" src="js/Common.js"></script>
	<script type="text/javascript" charset="utf-8">
		
		var ANIMATION = [];
		
	</script>
</head>
<body class="slide-26"><div id="main"><div id="content"> <div class="whiteoverlay"></div> <div id="logo"><img src="images/blkAbbott_logo.png" width="154" height="52" alt="Abbott"></div> <div id="title"> <h2>Adverse event rates were comparable between the KALETRA and raltegravir groups<sup>2</sup></h2> </div> <div id="leftchart" onclick="makecall('PopupMessageHTML',Array('ka-26-chart-01','Adverse Event Chart 1','450','365','0','0','830','570'));"> </div> <div class="smallcap"> <p>*Deemed by the investigator to be drug related.</p><p><span class="symbol">&dagger;</span>One patient in the KALETRA group had both a clinical and laboratory-associated adverse event that together led to discontinuation.</p> </div> <div id="rightcol"> <div class="blk_bullet">Clinical and laboratory adverse events occurred at similar frequencies in both treatment groups. Rates of serious adverse events were 5.4% for the raltegravir group and 5.1% for the KALETRA group.</div> <div class="blk_bullet">The only drug-realated clinical AE of moderate to severe intensity reported in <u>&gt;</u>1% in either treatment group was diarrhea, which occurred in 10 patients in the KALETRA group (3%) and no patients in the raltegravir group.</div> <h2>Common KALETRA adverse reactions</h2> <!--Tushar--> <div class="blk_bullet">In KALETRA clinical trials, the most common adverse reactions of moderate to severe intensity reported in &gt;5% of adult patients were diarrhea, nausea, abdominal pain, asthenia, vomiting, headache, and dyspepsia.</div> </div> <div class="btns"> <div class="studybtn"><a href="#"><img src="images/Button-StudyDesignA.png" width="132" height="42" alt="Study Design" onclick="makecall('PopupMessageHTMLWithTopnav',Array('ka-19-popup-01','<DIV align=\'left\'><font color=\'white\' face=\'Helvetica\'><p ><strong>}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}Study Design</strong></p></font></DIV>','780','670','10','0','575','460'));"></a></div> <div class="baselinebtn"><a href="#"><img src="images/Button-Baseline_A.png" width="132" height="42" alt="Baseline Values" onclick="makecall('PopupMessageHTMLWithTopnav',Array('ka-19-popup-02','<DIV align=\'left\'><font color=\'white\' face=\'Helvetica\'><p ><strong>}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}Baseline Values</strong></p></font></DIV>','920','670','10','0','580','350'));"></a></div> </div> <div id="footer"> <p>Please click buttons above for indication<br>and Important Safety Information about KALETRA.</p> </div> </div></div></body></html>